CASTRATION-SENSITIVE PROSTATE CANCER
Clinical trials for CASTRATION-SENSITIVE PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-SENSITIVE PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-SENSITIVE PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial: can hormone pills boost targeted cancer therapy?
Disease control Recruiting nowThis study is for men whose prostate cancer has come back in a few spots after radiation, but is still hormone-sensitive. Researchers want to see if adding a 12-month course of hormone therapy (ELIGARD) to targeted treatments like radiation or surgery helps keep the cancer from g…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CANCER
Phase: PHASE2 • Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can turmeric and metformin delay prostate cancer relapse?
Disease control Recruiting nowThis early-phase study is testing whether adding metformin and turmeric to standard hormone therapy can help control prostate cancer that is starting to grow again. About 34 men with rising PSA levels will take these supplements alongside their usual treatment. Researchers will t…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CANCER
Phase: PHASE1 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Timing matters: study seeks best moment for PSMA scans after hormone therapy
Knowledge-focused Recruiting nowThis study looks at how hormonal therapy changes PSMA levels in men with prostate cancer, both in early and advanced stages. Researchers will use PSMA PET scans at different times after starting therapy to see when the scan is most accurate for staging the cancer. The goal is to …
Matched conditions: CASTRATION-SENSITIVE PROSTATE CANCER
Phase: PHASE4 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC